We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

medicine×Panorama Data Insights Ltd. - List of Manufacturers, Suppliers, Companies and Products

medicine Product List

1~15 item / All 17 items

Displayed results

[Market Report] Global Market for Point-of-Care Diagnostic Tests

With the rapid increase in demand for swift and accurate testing, the global market for POC (point-of-care) diagnostic tests is experiencing rapid growth.

The global POC market is experiencing unprecedented growth due to the increasing demand for rapid and accurate testing solutions. Point-of-care diagnostic tests, also known as bedside testing or near-patient testing, enable timely decision-making by healthcare professionals and improve patient outcomes through rapid diagnosis and treatment. As the value of rapid and accurate testing is recognized by healthcare institutions worldwide in enhancing patient care and streamlining healthcare delivery, the global POC market is poised for continued growth. Please check the application method from the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Organ Transplant Rejection Treatment Drug Market

The global market for organ transplant rejection treatment drugs is rapidly expanding and is expected to reach 7 billion USD by 2031.

The global organ transplant rejection treatment drug market recorded a market size of 4.9 billion USD in 2022 and is expected to see significant expansion. It is projected to grow at a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2023 to 2031, reaching an estimated value of 7 billion USD by 2031. The driving forces behind this growth are the increase in organ transplant surgeries and advancements in immunosuppressive therapies. The growth of the global organ transplant rejection treatment drug market plays a crucial role in enhancing the quality of life for transplant recipients. Continuous technological innovations and advancements will make this market extremely important in ensuring the success of organ transplant surgeries worldwide. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Market for Neuropathic Pain Medications

The global market for neuropathic pain treatment drugs is expected to rapidly expand to $10.4 billion by 2031, alleviating suffering worldwide.

The global market for neuropathic pain medications is specialized in improving the lives of people suffering from neuropathic pain and has made significant progress. In 2022, this important market generated approximately $5.8 billion in revenue. It is projected to reach an estimated $10.4 billion by 2031, showing a stable compound annual growth rate (CAGR) of 5% during the forecast period from 2023 to 2031. Neuropathic pain is characterized by sharp, stabbing pain and burning sensations, often caused by nerve damage or dysfunction. Neuropathic pain is a complex condition that significantly impacts the quality of life for millions of people worldwide. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Market for Psoriasis Treatments

The global market for psoriasis treatments is expected to rapidly expand, reaching 55.72 billion USD by 2031.

The global market for psoriasis treatments has experienced significant growth and plays a crucial role in addressing this challenging skin condition. In 2022, the market size reached 25.2 billion USD and is projected to reach 55.72 billion USD by 2031. This notable increase indicates a steady compound annual growth rate (CAGR) of 9.3% during the forecast period from 2023 to 2031. Psoriasis is a chronic skin disease affecting millions of people worldwide, characterized by red, itchy, scaly patches on the skin's surface. The increasing prevalence of psoriasis, heightened awareness, and advancements in treatment options are driving the expansion of the psoriasis treatment market. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Market for Pulmonary Arterial Hypertension

The global market for pulmonary arterial hypertension is projected to reach 10.8 billion dollars by 2031.

The global pulmonary arterial hypertension (PAH) market reached a revenue of $7 billion in 2022 and is aiming for significant growth. Projections indicate that the market will reach $10.8 billion by 2031, with a compound annual growth rate (CAGR) of 5% from 2023 to 2031. This growth reflects the increasing demand for effective treatments for this serious and life-threatening disease. Pulmonary arterial hypertension is a rare but severe condition characterized by high blood pressure in the lungs. It involves narrowing or blockage of the pulmonary arteries and capillaries, leading to increased strain on the heart and gradually worsening symptoms. Without timely and effective treatment, PAH can be life-threatening, highlighting the urgent need for advanced treatment options. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Diabetic Nephropathy Market

The global diabetic nephropathy market is advancing in the fight against kidney disease, expected to reach 3.37 billion USD by 2031.

The global diabetic nephropathy market is at the forefront of combating kidney disorders in diabetic patients, offering hope and advanced treatment options. According to recent market reports, the global diabetic nephropathy market generated approximately $2 billion in revenue in 2022 and is estimated to surge to about $3.37 billion by 2031. This noteworthy growth trajectory is driven by a solid annual compound growth rate (CAGR) of 6% projected from 2023 to 2031. Diabetic nephropathy, a long-term kidney disorder, is a significant concern for those living with diabetes. This condition occurs when persistently elevated blood sugar levels cause damage to kidney function. Diabetic nephropathy can affect patients with type 2 diabetes and is primarily characterized by damage to the smallest blood vessels in the kidneys. When these small blood vessels are damaged, proteins begin to leak into the urine from both kidneys, indicating renal dysfunction. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Nucleic Acid Medicine Market

Global Nucleic Acid Drug Market: Expected to Reach 12 Billion USD by 2031 Due to Advances in Precision Medicine and Targeted Therapies.

The global nucleic acid therapeutics market is at the forefront of the pharmaceutical industry's push towards precision medicine and targeted therapies. According to recent market reports, the global nucleic acid therapeutics market is estimated to achieve approximately $4.5 billion in revenue by 2022 and surge to $12 billion by 2031. This remarkable growth trajectory is driven by powerful compounds. The compound annual growth rate (CAGR) is projected to be 11.6% from 2023 to 2031. Nucleic acid therapeutics encompass a wide range of innovative treatments, including ribonucleic acid (RNA) therapeutics and deoxyribonucleic acid (DNA) therapeutics. These therapies further include enzymes, antisense oligonucleotides, DNA aptamers, ribozymes, micro RNA, RNA decoys, and short interfering RNA, all designed to target disease-causing genes while preserving healthy cells and tissues. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Lyme Disease Treatment Market

The global Lyme disease treatment market is expected to achieve steady growth, reaching 1.652 billion USD by 2031.

The global Lyme disease treatment market is aiming for significant expansion, with revenues reaching approximately $799.4 million in 2022. Recent market analysis indicates that this sector is expected to experience a robust compound annual growth rate (CAGR) of 8.4% in 2022. The forecast period is from 2023 to 2031, with an estimated value of $1.652 billion by 2031. This increase is attributed to the rising global prevalence of Lyme disease and the development of innovative treatments. As the prevalence of Lyme disease continues to rise and research efforts focus on developing more effective treatment options, the global Lyme disease treatment market is poised for continuous growth. Increased investment in research and development, expanded access to healthcare, and heightened awareness of Lyme disease among healthcare professionals and the general public are expected to lead to significant advancements in the diagnosis and treatment of this debilitating disease. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Market for Hemophilia Treatment

World Market for Hemophilia Treatment: Advances in medical therapies that enhance patient quality of life in the management of this rare bleeding disorder.

The global hemophilia treatment market is making significant progress as advancements in medical therapies innovate the management of this rare bleeding disorder. Hemophilia is a condition caused by genetic factors that impairs the blood's ability to clot properly, leading to prolonged bleeding times and an increased risk of severe bleeding symptoms. However, the emergence of innovative treatments has allowed patients to experience improved outcomes and enhanced quality of life. According to the latest market report, the global hemophilia treatment market reached $12.8 billion in 2021, with a steady growth forecast of a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] The Global Market for Erectile Dysfunction

The global erectile dysfunction market is expected to enhance men's health and show significant growth.

The global erectile dysfunction (ED) market is focused on enhancing men's health and well-being, recording approximately $2.3 billion in sales in 2022. With a promise to address critical aspects of men's health, industry experts predict that this market will achieve an estimated revenue of $4.7 billion by 2031. This anticipated surge highlights a significant compound annual growth rate (CAGR) of 8.5% during the forecast period from 2023 to 2031. Erectile dysfunction is a symptom that affects the quality of life for men and is a significant concern for both individuals and the medical community. The global ED market serves as a beacon of hope for men seeking effective solutions to restore confidence, intimacy, and overall well-being. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Market for Gabapentin

The global market for Gabapentin is thriving, expected to reach 292 million USD by 2031.

The global gabapentin market has experienced significant growth, with sales surging to approximately $1.9816 billion in 2022. This upward trend is expected to continue, with a projected compound annual growth rate (CAGR) of 4.37% during the forecast period from 2023 to 2031, reaching an estimated $2.912 billion by 2031. Gabapentin, a widely used medication, has garnered considerable attention in the healthcare sector due to its effectiveness in treating various conditions. It belongs to the class of anticonvulsants and is primarily prescribed for the management of epilepsy and neuropathic pain. In addition to these uses, gabapentin has also been recognized for its utility in treating anxiety disorders, restless legs syndrome, and as an adjunct therapy for individuals suffering from opioid withdrawal. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Market for Heart Failure Treatment Drugs

The global market for heart failure treatment drugs is expected to exceed 49.6 billion USD by 2031.

The global heart failure treatment drug market is on an upward trend, with revenues projected to reach $49.6 billion by 2031. This significant growth, driven by an attractive compound annual growth rate (CAGR) of 9.43% from 2023 to 2031, underscores the urgent need for advanced treatments and therapies to combat heart failure. The growth forecast for the global heart failure treatment drug market reflects ongoing efforts to improve the quality of life for individuals suffering from heart failure. As medicine advances and new treatments emerge, the outlook for heart failure patients is becoming increasingly optimistic. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Market for Skin Cancer Treatment

The global market for skin cancer treatment is rapidly expanding and is expected to reach 14.5 billion USD by 2031.

As the battle against skin cancer, one of the most common cancers, continues, the global skin cancer treatment market is emerging as a bastion of hope. This market recorded a solid revenue of approximately 7.72 billion USD in 2022 and is expected to achieve a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2023 to 2031, indicating remarkable growth. By 2031, it is projected to reach an astonishing valuation of 14.5 billion USD. Skin cancer is often caused by excessive sunbathing and ultraviolet rays, and there is growing global concern about it. The rising incidence of skin cancer and increasing awareness of the importance of early diagnosis and treatment are driving demand for advanced and effective skin cancer treatment options. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] The Global Market for Oral Ulcer Treatment

The global market for oral mucositis treatment is projected to reach 1.92 billion dollars by 2031.

The global oral ulcer treatment market, which achieved sales of 1.34 billion USD in 2022, is steadily growing and is projected to reach 1.92 billion USD by 2031. This growth is progressing at a compound annual growth rate (CAGR) of 4.1% from 2023 to 2031, reflecting the increasing demand for effective treatments for this common oral condition. Oral ulcers are characterized by painful sores or lesions on the oral mucosa, significantly impacting an individual's quality of life (QOL). These ulcers can appear on the cheeks, lips, tongue, gums, the roof and floor of the mouth, and sometimes even the esophagus. Generally, oral ulcers present as lesions with a red outer ring and a pale or yellow center, causing discomfort or pain, especially during eating and drinking. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Market Report] Global Inflammatory Bowel Disease Treatment Market

The global inflammatory bowel disease treatment market is expected to achieve steady growth, reaching 34 billion USD by 2031.

The global inflammatory bowel disease (IBD) treatment market is on an upward trajectory, with revenues reaching approximately $22 billion in 2022, and an estimated value of $34 billion by 2031. This significant growth is projected to occur at a compound annual growth rate (CAGR) of 5.1% during the forecast period from 2023 to 2031. Inflammatory bowel disease (IBD) is a chronic condition characterized by inflammation of the gastrointestinal tract. It primarily consists of two distinct conditions: Crohn's disease and ulcerative colitis. Crohn's disease is known for causing inflammation and discomfort in various parts of the gastrointestinal tract, often affecting the small intestine and the upper part of the large intestine. On the other hand, ulcerative colitis primarily causes pain and inflammation in the colon. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine